{
  "docId": "019de074-e81b-753e-9153-de7ee222684a",
  "docSlug": "eb349ec8590aecb3f4d8a8e322d8bfa8",
  "documentTitle": "Exscientia | Investor Presentation Deck | 45 slides",
  "authorId": "exscientia",
  "authorName": "Exscientia",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 27,
  "pageCount": 45,
  "prevPage": 26,
  "nextPage": 28,
  "slideType": "competitive_analysis",
  "function": "compare_peers",
  "density": "dense",
  "nDataPoints": 45,
  "notes": "The slide uses a color-coded heatmap (green/yellow/red/grey) to indicate performance against design criteria.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-e81b-753e-9153-de7ee222684a/27",
  "deckHref": "/decks/019de074-e81b-753e-9153-de7ee222684a",
  "deckJsonHref": "/decks/019de074-e81b-753e-9153-de7ee222684a.json",
  "deckAnchorHref": "/decks/019de074-e81b-753e-9153-de7ee222684a#slide-27",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.12,
        "x": 0.86,
        "y": 0.35
      },
      "kind": "callout",
      "text": "Design criteria met in only 344 compounds synthesised",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "548ad218-2b7c-4607-a5af-aac2ac5aec32",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.45,
        "x": 0.27,
        "y": 0.86
      },
      "kind": "legend",
      "text": "Meets or exceeds criteria (green), Minor deviation (yellow), Major deviation (red), Not tested (grey)",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d90fe892-2610-42b6-be87-3bc3e88b3c06",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.85,
        "x": 0.07,
        "y": 0.25
      },
      "kind": "table",
      "text": "Comparison table of MALT1 inhibitors across 9 parameters and 5 categories (Phase 1/2 Large Pharma, Phase 1 Large Pharma, Phase 1 Mid-size Pharma, Phase 1 Biotech, EXS73565)",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0505a4e0-da78-4c62-91aa-cfe148d33362",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.6,
        "x": 0.07,
        "y": 0.13
      },
      "kind": "title",
      "text": "Most competitor compounds have a high UGT1A1 inhibition risk",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1c8fd79b-56bd-48f6-8099-2dca4af0a431",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.45,
        "x": 0.07,
        "y": 0.06
      },
      "kind": "title",
      "text": "MALT1 allosteric competitor profiles",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fdedbe99-cc5e-41a8-9781-b6009358b627",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "comparison_frame",
      "slug": null,
      "matchId": "61117854-3c7e-4231-a45f-6fc743993e2d",
      "evidence": "Table comparing competitor profiles against specific criteria",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}